Variman Global Enterprises announced that an Extra Ordinary General Meeting EGM of the Company will be held on 11 April 2022
Captain Technocast will hold a meeting of the Board of Directors of the Company on 21 March 2022
Repco Home Finance announced the resignation of L Munishwar Ganesan DIN 07082752 a Non-Executive and Non-Independent Director of the company with immediate effect
REC announced that after receipt of consideration comprising of professional fee for bid process coordination interest cost and reimbursement of expenditure incurred on the project by REC Power Development Consultancy RECPDCL wholly owned subsidiary of REC the entire shareholding of Gadag Transmission comprising of 50000 equity shares presently held by RECPDCL has been transferred at par value along with all its assets and liabilities on […]
DLF announced that ICRA based on a review of the latest developments has upgraded its long-term rating on the Banking Facilities and Non-convertible Debentures NCDs of DLF Cyber City Developers DCCDL a material subsidiary Company to ICRA AA Stable from ICRA AA- Minus Stable
Gati has granted 3105000 Employees Stock Appreciation Rights ESARs to eligible employees under Gati – Employees Stock Appreciation Rights Plan 2021
Gujarat Fluorochemicals -New will hold a meeting of the Board of Directors of the Company on 23 March 2022
Kirloskar Brothers has appointed Devang Trivedi as company secretary and compliance officer with immediate effect
ITC has allotted 355840 ordinary shares of Re 1 each upon exercise of 35584 Options by Optionees under the Companys Employee Stock Option Scheme Consequently with effect from 17 March 2022 the Issued and Subscribed Share Capital of the Company stands increased to 12323255931 divided into 12323255931 Ordinary Shares of 1 each
Akston Biosciences Corporation a developer of new classes of biologic therapeutics and Biolexis a division of Stelis Biopharma Stelis announced today that they have entered into a licensing manufacturing and commercialization agreement for Akstons AKS-452 a protein subunit COVID-19 vaccine Under the agreement Biolexis gains the right to manufacture and commercialize AKS-452 branded as AmbiVax-Ctrade; in India and over 130 countries in Asia Latin America […]

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.